PRE 14C

PRELIMINARY INFORMATION STATEMENT

Company: Silo Pharma, Inc.
Filed: May 23, 2017
Period of Report: May 23, 2017
Accession Number: 0001213900-17-005766

View Document ↗ View on SEC.gov ↗